Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.
about
Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattentionClinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic reviewNovel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York CityMetropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSTrends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007Antibody responses to lytic and latent human herpesvirus 8 antigens among HIV-infected patients in central China.Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada.Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.Prevention and treatment of HIV/AIDS among drug-using populations: a global perspectiveNephrotoxicity of HAARTSocial and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysisFactors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV careImpact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users."I Do Not Take My Medicine while Hiding" - A Longitudinal Qualitative Assessment of HIV Discordant Couples' Beliefs in Discordance and ART as Prevention in Uganda.Mediators of antiretroviral adherence: a multisite international studyThe unrealized potential of addiction science in curbing the HIV epidemicHIV counselling and testing practices for children seen in an urban emergency department of a tertiary referral hospital in Dar es Salaam, Tanzania: a retrospective cross-sectional studyImprovements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian settingChanges in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysisPlasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?Antiretrovirals for HIV prevention: when should they be recommended?Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting.Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing.Harder-to-reach people living with HIV experiencing high prevalence of all-type mental health disorder diagnosis.Data Collection and Harmonization in HIV Research: The Seek, Test, Treat, and Retain Initiative at the National Institute on Drug Abuse.
P2860
Q27008531-B34BD293-4577-454B-B7EC-AA804B90F307Q27026742-632FF253-DE72-4042-8239-834E437612ECQ28479045-30F4B8A4-CC64-4EFA-A81E-1E55F1C3125BQ28486380-B3961D52-B787-48B3-9960-416A339B8982Q28533642-471D0337-943A-41F0-863E-1022B6D66F76Q33593814-9FC17DFD-7F13-480C-B957-D8C46CD6C247Q33787580-4C896617-3966-4124-9BFF-B5425D03DD3AQ34592711-17695B9D-3DE5-46FA-9C71-099F9A782440Q34780130-07C83C49-CB38-4AD8-905E-1BEF7B817B9CQ35167944-13C55BDD-0B01-4664-9D97-E8E94A2C6A6EQ35823204-FD5BA477-4BE3-4E5F-A1C3-A1B4A61996FCQ36045908-A1F59535-D0B5-4406-A9E5-E49948D8142FQ36115179-BEB9E525-402A-4C34-9F22-57748AAC5360Q36123462-2196C8D9-3F08-46AE-BF85-4BBEB9CC466CQ36167178-FFD5A2AC-ACC2-4FE7-8728-1895189C85D0Q36177517-E0E5EC83-0C3B-46BD-A564-F49F5837397BQ36247508-B9AE91CF-1C2D-4851-B1F8-B8EFE9C70904Q36377371-9DDF38C1-22F5-4BFD-8E39-8869F6FFBDB8Q36460643-60207A16-E25E-4E1A-9ADE-0F46E81EF3E9Q36602865-F4D2014C-54FC-4E26-A6C7-8B00353F2170Q36814748-F4B9EC0F-3CE0-4689-8964-F0D53AFBC6A9Q36919650-1344A11C-7762-4EE0-A3BE-358D7F6783C9Q37066888-B0632FE3-9D17-4271-81C1-E5C8B4BDE6A9Q37125639-F1551FD1-FC4A-4A1D-A25C-6E5A72E062EBQ38173892-4C2278ED-2461-4661-A9A5-E3BE307CB561Q38195335-8C1F4EF8-8196-414D-AACA-E60A69BC4527Q38864466-0EE7C7F8-D2C3-474B-BD20-CEC0B0453DC1Q39024978-9A2816E5-7644-48CB-B10E-22021EE33DA0Q39408764-468BA09D-1B8F-44D1-B4DE-46DE88495157Q54742023-224833DF-2DDA-4FD4-A770-7BE22B6D5397
P2860
Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expanded highly active antiret ...... al and public health outcomes.
@ast
Expanded highly active antiret ...... al and public health outcomes.
@en
type
label
Expanded highly active antiret ...... al and public health outcomes.
@ast
Expanded highly active antiret ...... al and public health outcomes.
@en
prefLabel
Expanded highly active antiret ...... al and public health outcomes.
@ast
Expanded highly active antiret ...... al and public health outcomes.
@en
P2093
P50
P1476
Expanded highly active antiret ...... al and public health outcomes.
@en
P2093
Kate Shannon
Richard Harrigan
Rolando Barrios
Viviane Lima
P356
10.1097/QAI.0B013E3181F9C1F0
P407
P478
55 Suppl 1
P577
2010-12-01T00:00:00Z